Otsuka Pharma GmbH distributes pharmaceuticals and medical devices in Germany and Austria and operates within a DACH organization responsible for Germany, Austria and Switzerland. Distributed products include Abilify, Abilify Maintena, Samsca, Jinarc and Inaqovi, and Lupkynis in Austria; Abilify Maintena has been marketed in Germany since June 2014 together with Lundbeck. The company also provides intragroup services in clinical research, pharmacovigilance, quality management and regulatory affairs and employs around 40 staff in these functions; on average 119 employees worked in fiscal year 2024. Products are manufactured in Japan; goods are purchased from affiliated companies at the time of sale and distribution and invoicing are performed by Arvato Distribution GmbH.
Forschung, Entwicklung und Vertrieb von pharmazeutischen, diagnostischen sowie Produkten für die Gesundheitsvorsorge und Durchführung von Zulassungsverfahren für Arzneimittel.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 46388 (as of 27 September 2026)
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 46388 (as of 27 September 2026)
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 46388 (as of 27 September 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 46388 (as of 27 September 2026)
Hasso-Plattner-Institut für Digital Engineering gGmbH
Potsdam · Sonstige Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin
Chr. Hansen HMO GmbH
Rheinbreitbach · Forschung und Entwicklung im Bereich Biotechnologie
Proteros biostructures GmbH
Planegg-Martinsried · Forschung und Entwicklung im Bereich Biotechnologie
Sign in to view detailed salary and cost trends.
